Distinct features of distant metastasis and lymph node stage in lung adenocarcinoma patients with epidermal growth factor receptor gene mutations

Respiratory Investigation

Volumn 51, Issue 3, 2013, Pages 153-157

  Enomoto, Yasunori ^a   Takada, Kazuto ^a   Hagiwara, Eri ^b   Kojima, Eiji ^a  

^a KOMAKI CITY HOSPITAL   (Japan)

^b Kanagawa Prefectural Cardiovascular and Respiratory Diseases Center Hospital   (Japan)

Author keywords

Brain metastasis; Epidermal growth factor receptor (EGFR); Lung adenocarcinoma; Lymph node stage; Pulmonary metastasis

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; BRAIN METASTASIS; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; DISTANT METASTASIS; EPIDERMAL GROWTH FACTOR RECEPTOR GENE; EXON; FEMALE; GENE DELETION; GENE MUTATION; HUMAN; LIVER METASTASIS; LUNG ADENOCARCINOMA; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; POINT MUTATION; RETROSPECTIVE STUDY; TUMOR GENE;

BRAIN METASTASIS; EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR); LUNG ADENOCARCINOMA; LYMPH NODE STAGE; PULMONARY METASTASIS;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MUTATION; NEOPLASM METASTASIS; NEOPLASM STAGING; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETROSPECTIVE STUDIES;

EID: 84882912633     PISSN: 22125345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resinv.2013.02.004     Document Type: Article

References (18)

1. Mitsudomi T., Morita S., Yatabe Y., et al. Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomized phase 3 trial. Lancet Oncol 2009, 11:121-128.
2. Petrelli F., Borgonovo K., Cabiddu M., et al. Efficacy of EGFR tyrosyne kinase inhibitors in patients with EGFR-mutated non-small-cell lung cancer: a meta-analysis of 13 randomized trials. Clin Lung Cancer 2012, 13:107-114.
3. Inoue A., Kobayashi K., Usui K., et al. First-line gefitinib for patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations without indication for chemotherapy. J Clin Oncol 2009, 27:1394-1400.
4. Shigematsu H., Lin L., Takahashi T., et al. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst 2005, 97:339-346.
5. Zhang X.T., Li L.Y., Mu X.L. The EGFR mutation and its correlation with response of gefitinib in previously treated Chinese patients with advanced non-small-cell lung cancer. Ann Oncol 2005, 16:1334-1342.
6. Calvo E., Baselga J. Ethnic differences in response to epidermal growth factor receptor tyrosine kinase inhibitors. J Clin Oncol 2006, 24:2158-2163.
7. Glynn C., Zakowski M.F., Ginsberg M.S. Are there imaging characteristics associated with epidermal growth factor receptor and KRAS mutations in patients with adenocarcinoma of lung with bronchioloalveolar features?. J Thorac Oncol 2010, 5:344-348.
8. Huang C.T., Yen R.F., Cheng M.F., et al. Correlation of F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value and EGFR mutations in advanced lung adenocarcinoma. Med Oncol 2010, 27:9-15.
9. Park E.A., Lee H.J., Kim Y.T., et al. EGFR gene copy number in adenocarcinoma of the lung by FISH analysis: investigation of significantly related factors on CT, FDG-PET, and histopathology. Lung Cancer 2009, 64:179-186.
10. Yano M., Sasaki H., Kobayashi Y., et al. Epidermal growth factor receptor gene mutation and computed tomographic findings in peripheral pulmonary adenocarcinoma. J Thorac Oncol 2006, 1:413-416.
11. Nagai Y., Miyazawa H., Huqun, et al. Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp. Cancer Res 2005, 65:7276-7282.
12. Mori K., Yokoi K., Saito K., et al. Diagnosis of mediastinal lymph node metastases in lung cancer. Jpn J Clin Oncol 1992, 22:35.
13. Seely J.M., Mayo J.R., Miller R.R., et al. T1 lung cancer: prevalence of mediastinal nodal metastases and diagnostic accuracy of CT. Radiology 1993, 186:129.
14. Togashi Y., Masago K., Kubo T., et al. Association of diffuse, random pulmonary metastases, including miliary metastases, with epidermal growth factor receptor mutations in lung adenocarcinoma. Cancer 2011, 117:819-825.
15. Laack E., Simon R., Regier M., et al. Miliary never-smoking adenocarcinoma of the lung: strong association with epidermal growth factor receptor exon 19 deletion. J Thorac Oncol 2011, 6:199-202.
16. De Luca A., Carotenuto A., Rachiglio A., et al. The role of the EGFR signaling in tumor microenvironment. J Cell Physiol 2008, 214:559-567.
17. Sekine A., Kato T., Hagiwara E., et al. Metastatic brain tumors from non-small cell lung cancer with EGFR mutations: distinguishing influence of exon 19 deletion on radiographic features. Lung Cancer 2012, 77:64-69.
18. Gould M.K., Kuschner W.G., Rydzak C.E., et al. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis. Ann Int Med 2003, 139:879-892.